Cargando…
Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
Phelan–McDermid syndrome (PMS), caused by pathogenic variants in the SHANK3 gene or 22q13 deletions, is characterized by intellectual disability, autistic features, developmental delays, and neonatal hypotonia. Insulin-like growth factor 1 (IGF-1) and human growth hormone (hGH) have been shown to re...
Autores principales: | Moffitt, Bridgette A., Sarasua, Sara M., Ivankovic, Diana, Ward, Linda D., Valentine, Kathleen, Bennett, William E., Rogers, Curtis, Phelan, Katy, Boccuto, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956088/ https://www.ncbi.nlm.nih.gov/pubmed/36833418 http://dx.doi.org/10.3390/genes14020490 |
Ejemplares similares
-
Sleep and Phelan–McDermid Syndrome: Lessons from the International Registry and the scientific literature
por: Moffitt, Bridgette A., et al.
Publicado: (2022) -
Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome
por: Dyar, Brianna, et al.
Publicado: (2021) -
Phenotypic Variability in Phelan–McDermid Syndrome and Its Putative Link to Environmental Factors
por: Boccuto, Luigi, et al.
Publicado: (2022) -
Position effects of 22q13 rearrangements on candidate genes in Phelan-McDermid syndrome
por: Srikanth, Sujata, et al.
Publicado: (2021) -
Phelan-McDermid syndrome: a classification system after 30 years of experience
por: Phelan, Katy, et al.
Publicado: (2022)